Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes - Concepedia

Concepedia

Publication | Open Access

Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes

DOI Full Paper Access

101

Citations

19

References

2009

Year

Maria Teresa Voso, Valeria Santini, Carlo Finelli, Pellegrino Musto, Enrico Pogliani, Emanuele Angelucci, Giuseppe Fioritoni, Giuliana Alimena, Luca Maurillo, Agostino Cortelezzi,

Clinical Cancer Research

Abstract

Our data show that the 5-AZA/VPA combination is active and safe in patients with MDS with a poor prognosis. Achievement of VPA therapeutic levels may indeed increase 5-AZA efficacy.

References

	Year	Citations

Page 1